IL108881A0 - Pharmaceutical compositions containing a combination of verapamil and trandolapril - Google Patents

Pharmaceutical compositions containing a combination of verapamil and trandolapril

Info

Publication number
IL108881A0
IL108881A0 IL10888194A IL10888194A IL108881A0 IL 108881 A0 IL108881 A0 IL 108881A0 IL 10888194 A IL10888194 A IL 10888194A IL 10888194 A IL10888194 A IL 10888194A IL 108881 A0 IL108881 A0 IL 108881A0
Authority
IL
Israel
Prior art keywords
trandolapril
verapamil
combination
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL10888194A
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of IL108881A0 publication Critical patent/IL108881A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10888194A 1993-03-18 1994-03-07 Pharmaceutical compositions containing a combination of verapamil and trandolapril IL108881A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4308504A DE4308504A1 (en) 1993-03-18 1993-03-18 New use of a combination of verapamil and trandolapril

Publications (1)

Publication Number Publication Date
IL108881A0 true IL108881A0 (en) 1994-06-24

Family

ID=6483047

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10888194A IL108881A0 (en) 1993-03-18 1994-03-07 Pharmaceutical compositions containing a combination of verapamil and trandolapril

Country Status (4)

Country Link
AU (1) AU6376694A (en)
DE (1) DE4308504A1 (en)
IL (1) IL108881A0 (en)
WO (1) WO1994021285A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733911B1 (en) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd PHARMACEUTICAL COMPOSITION FOR RENAL OR CARDIOVASCULAR DISEASES
SE9903028D0 (en) * 1999-08-27 1999-08-27 Astra Ab New use
ES2246894T3 (en) 1999-08-30 2006-03-01 Sanofi-Aventis Deutschland Gmbh RAMIPRIL FOR THE PREVENTION OF CARDIOVASCULAR EVENTS.
WO2003032965A2 (en) * 2001-10-17 2003-04-24 King Pharmaceuticals Research And Development, Inc Use of ace inhibitors for reducing type 2 diabetes in high risk patients
GB0318094D0 (en) * 2003-08-01 2003-09-03 Pfizer Ltd Novel combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4109134A1 (en) * 1991-03-20 1992-09-24 Knoll Ag PRODUCTS CONTAINING VERAPAMIL AND TRANDOLAPRIL

Also Published As

Publication number Publication date
DE4308504A1 (en) 1994-09-22
WO1994021285A1 (en) 1994-09-29
AU6376694A (en) 1994-10-11

Similar Documents

Publication Publication Date Title
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL105220A0 (en) Cyclohexanylidene compounds and pharmaceutical compositions containing them
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
IL105221A0 (en) Cyclohexane derivatives and pharmaceutical compositions containing them
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
NZ314376A (en) Substituted sulphonamides and pharmaceutical compositions
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
IL107587A0 (en) Farnesyl derivatives and pharmaceutical compositions containing them
IL111518A (en) Isoquinolines their preparation and pharmaceutical compositions containing them
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
IL105222A0 (en) Cyclohex-1-ene compounds and pharmaceutical compositions containing them
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
IL108073A0 (en) Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them
IL125775A0 (en) Use of a zwitterion composition and a pharmaceutical composition containing the same
IL105551A0 (en) Quinazolines and pharmaceutical compositions containing them
ZA948689B (en) New taxicin derivatives their preparation and pharmaceutical compositions containing them
IL98680A0 (en) Hydroxamate derivatives and pharmaceutical compositions containing them
IL108881A0 (en) Pharmaceutical compositions containing a combination of verapamil and trandolapril
ZA944769B (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
GB9304745D0 (en) Use of pharmaceutical formulations
IL92650A0 (en) Polyhydroxybenzyloxypropanolamides and pharmaceutical compositions containing them
PH30103A (en) Pharmaceutical compositions containing amidines and novel amidines
IL106352A0 (en) Pyridoindolo-benzodiazepines and pharmaceutical compositions containing them
IL110336A0 (en) Pharmaceutical compositions containing a combination of esuprone and levodopa, and their preparation